Your browser doesn't support javascript.
loading
VersaCross Transseptal System for Mitral Transcatheter Edge-To-Edge Repair With the PASCAL Repair Platform.
Doshi, Sagar N; Savvoulidis, Panagiotis; Mechery, Anthony; Lawton, Ewa; Nadir, M Adnan.
Afiliação
  • Doshi SN; Department of Cardiology, Queen Elizabeth University Hospital, Birmingham, UK.
  • Savvoulidis P; Institute for Cardiovascular Sciences, College of Medical & Dental Sciences, University of Birmingham, Birmingham, UK.
  • Mechery A; Department of Cardiology, Queen Elizabeth University Hospital, Birmingham, UK.
  • Lawton E; Department of Cardiology, Queen Elizabeth University Hospital, Birmingham, UK.
  • Nadir MA; Department of Cardiology, Queen Elizabeth University Hospital, Birmingham, UK.
Struct Heart ; 7(6): 100203, 2023 Nov.
Article em En | MEDLINE | ID: mdl-38046864
ABSTRACT

Background:

VersaCross is a novel radiofrequency transseptal solution that may improve the efficiency and workflow of transseptal puncture (TSP). The aim of this study was to compare the VersaCross transseptal system with mechanical needle systems during mitral transcatheter edge-to-edge repair (M-TEER) with the PASCAL device.

Methods:

This is a single-center retrospective study of consecutive patients who underwent M-TEER with the PASCAL. Transseptal puncture was undertaken with either a mechanical needle or the VersaCross wire. The primary endpoints were success of TSP and successful delivery of the Edwards sheath on the chosen delivery wire. Secondary endpoints included number of wires used, tamponade rate, interval from femoral venous access to TSP and first PASCAL device deployment, procedural death, and stroke.

Results:

Thirty-three consecutive patients (10 with mechanical needle, 23 with VersaCross) who underwent M-TEER with the Edwards PASCAL device were identified. All patients had successful TSP. In the mechanical needle group, the Edwards sheath was successfully delivered on the Superstiff Amplatz wire in all cases. In the VersaCross arm, the radiofrequency wire was used successfully for delivery of the sheath in all cases. There were no cases of pericardial effusion/tamponade in either arm. Interval from femoral venous access to TSP and to deployment of the first PASCAL device was shorter with the VersaCross system. Significantly fewer wires were used with VersaCross. There were no procedural deaths or strokes in either group.

Conclusions:

VersaCross appears a safe and effective method of TSP and for delivery of the 22Fr sheath for M-TEER with PASCAL.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Struct Heart Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Struct Heart Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido